Specialty Testing
We offer special tests to our members that want to take a deeper dive into their health.
MyOme Single-Gene Risk
Screens ~151 actionable genes for pathogenic variants linked to adult-onset cancers, cardiovascular disease, and metabolic disorders - even without a family history.
Cancers — BRCA1/2, Lynch syndrome, familial colon, prostate, ovarian, skin
Cardiovascular — Cardiomyopathies, arrhythmias, familial hypercholesterolemia
Other — Clotting disorders, metabolic disease, metal metabolism
How It Works
Sample Collection Blood draw or buccal swab. One sample covers all three tests — collected in-office or sent as an at-home kit.
Sequencing & Analysis Clinical-grade 30× whole-genome sequencing at a CLIA-certified, CAP-accredited lab. Results in 5–6 weeks.
Practitioner Review & Counseling Your practitioner walks through every result — translating risk scores into clear, personalized next steps.
Your Genome Has the Answers. Now Medicine Can Read Them.
Galleri Cancer Screening
The Galleri test gives you more control when it comes to cancer screenings.
The Galleri test screens for a unique "fingerprint" of cancer from DNA fragments shed from cancer cells. Around 1% of people ages 50-79 are expected to receive a Cancer Signal Detected test result. This result will include the predicted tissue type or organ associated with the signal, called a Cancer Signal Origin (CSO). After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis.
In a clinical study, participants with a cancer diagnosis after a Cancer Signal Detected test result, the CSO was accurate 93.4% of the time. The predicted CSO provides direction to your doctor on the cancer’s origin and helps guide the next steps in diagnosis.